Wickliffe Pharmaceutical, Inc.

Untitled letter issued June 10, 2024 · Kentucky

Pages: 7
FEI number: 3002992930

In short: On June 10, 2024, FDA sent an untitled letter to Wickliffe Pharmaceutical, Inc. in Kentucky (FEI 3002992930): an enforcement letter for violations that don't rise to warning-letter level.

Inside this untitled letter

The full untitled letter

Every page of the untitled letter, exactly as written.

Get the full untitled letter

This inspection in context

The firm

Wickliffe Pharmaceutical, Inc. history

All 8 documents on file for this site, in date order, with what was cited at each inspection.

Complete the picture

Response
The firm's reply to this letterJul 23, 2024$199

Wickliffe Pharmaceutical, Inc. site file

All 8 documents for this site in one go: $843 instead of ~~$992~~, 15% off.

See the site history

Questions about this untitled letter

When was Wickliffe Pharmaceutical, Inc. inspected by FDA?

This Untitled letter is dated June 10, 2024.

How do I get the full Untitled letter for Wickliffe Pharmaceutical, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.